TFPI fragments as anti-microbial agents

Details for Australian Patent Application No. 2006272653 (hide)

Owner Novartis AG

Inventors Schirm, Sabine; Hardy, Stephen; Dai, Yumin

Agent Davies Collison Cave

Pub. Number AU-A-2006272653

PCT Pub. Number WO2007/014199

Priority 60/722,512 29.09.05 US; 60/702,049 22.07.05 US

Filing date 24 July 2006

Wipo publication date 1 February 2007

International Classifications

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

14 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014199 Priority application(s): WO2007/014199

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272654-Method and system for transacting with a trading application

2006272652-1,2,3-triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders